This Diagnosing Health Care episode dives into the status of the Food and Drug Administration’s (“FDA’s”) plan for regulating cannabis and cannabis-derived products and what actions the agency has taken recently to make progress. The episode features Delia Deschaine and is hosted by Megan Robertson, both attorneys in the Washington, DC, office of Epstein Becker Green.
Here’s a preview of what you’ll hear:
“As we started to learn more about the plant’s therapeutic See more +
This Diagnosing Health Care episode dives into the status of the Food and Drug Administration’s (“FDA’s”) plan for regulating cannabis and cannabis-derived products and what actions the agency has taken recently to make progress. The episode features Delia Deschaine and is hosted by Megan Robertson, both attorneys in the Washington, DC, office of Epstein Becker Green.
Here’s a preview of what you’ll hear:
“As we started to learn more about the plant’s therapeutic potential, the interest in developing potential medical therapies that contain cannabinoids has exponentially grown.” – Delia Deschaine, Member of the Firm
“While there's been some positive movement, a lot of barriers still exist for researchers to kind of create that initial threshold comfortable level for FDA safety with respect to these products.” – Megan Robertson, Associate
The Diagnosing Health Care podcast examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Visit http://www.DiagnosingHealthCare.com See less -
